Prostate cancer : multimodality approaches with docetaxelSENZER, Neil N.Seminars in oncology. 2001, Vol 28, Num 4, pp 77-85, issn 0093-7754, SUP15Article

Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumorsMAHALINGAM, Devalingam; NEMUNAITIS, John J; CHARLES, John et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 6, pp 1241-1250, issn 0344-5704, 10 p.Article

Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast CancerLOESCH, David; GRECO, F. Anthony; PIPPEN, John et al.Journal of clinical oncology. 2010, Vol 28, Num 18, pp 2958-2965, issn 0732-183X, 8 p.Article

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neckSOULIERES, Denis; SENZER, Neil N; VOKES, Everett E et al.Journal of clinical oncology. 2004, Vol 22, Num 1, pp 77-85, issn 0732-183X, 9 p.Article

Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): Early termination due to increased toxicitiesMESSERSMITH, Wells A; LAHERU, Daniel A; SENZER, Neil N et al.Clinical cancer research. 2004, Vol 10, Num 19, pp 6522-6527, issn 1078-0432, 6 p.Article

875 benzydamine HCI for prophylaxis of radiation-induced oral mucositis: Results from a multicenter, randomized, double-blind, placebo-controlled clinical trialEPSTEIN, Joel B; SILVERMAN, Sol JR; PAGGIARINO, Dario A et al.Cancer. 2001, Vol 92, Num 4, pp 875-885, issn 0008-543XArticle

Phase 1 study of N¹,N¹¹-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinomaGOYAL, Lipika; SUPKO, Jeffrey G; CHAN, Emily et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 6, pp 1305-1314, issn 0344-5704, 10 p.Article

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non-Small-Cell Lung CancerSEQUIST, Lecia V; GETTINGER, Scott; SWEENEY, Jennifer et al.Journal of clinical oncology. 2010, Vol 28, Num 33, pp 4953-4960, issn 0732-183X, 8 p.Article

Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic MelanomaSENZER, Neil N; KAUFMAN, Howard L; GOLDSWEIG, Howard et al.Journal of clinical oncology. 2009, Vol 27, Num 34, pp 5763-5771, issn 0732-183X, 9 p.Article